Renin–angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection
In this cohort of patients with HBV infection, new users of ACEIs/ARBs had a lower risk of incident HCC, liver-related mortality, and new-onset cirrhosis than new users of CCBs/THZs.
Authors
- Yuxin Lin (ORCID: https://orcid.org/0000-0001-6543-0317)
- Sheng Nie (ORCID: https://orcid.org/0000-0002-8267-7909)
- Yanqin Li (ORCID: https://orcid.org/0000-0001-5107-1296)
- Xin Xu (ORCID: https://orcid.org/0000-0002-0728-0821)
- Zhi‐Xin Guo (ORCID: https://orcid.org/0000-0002-5654-9217)
- Licong Su (ORCID: https://orcid.org/0000-0002-3085-909X)
- Xiaodong Zhang (ORCID: https://orcid.org/0000-0002-7940-802X)
- Lu Li (ORCID: https://orcid.org/0000-0002-7302-8528)
- Fan Luo (ORCID: https://orcid.org/0009-0003-5048-543X)
- Lisha Cao
- Ruixuan Chen (ORCID: https://orcid.org/0000-0002-2925-9484)
- Shiyu Zhou (ORCID: https://orcid.org/0000-0002-6564-9666)
- Qi Gao (ORCID: https://orcid.org/0000-0001-8813-8554)
- Chuyao Fang
- Jiao Liu (ORCID: https://orcid.org/0009-0001-8953-883X)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- Canadian Medical Association Journal
- Published
- 2024-08-11
- DOI
- https://doi.org/10.1503/cmaj.240003
- Citations
- 7
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China